Roderick P J, Brennan P J, Meade T W
Medical Research Council Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Medical College, St Bartholomew's Hospital, London, UK.
J Cardiovasc Risk. 1995 Aug;2(4):353-7.
There has been an increasing focus on the identification and modification of risk factors for coronary heart disease (CHD) in primary care. One approach is to concentrate activity on those at high risk of CHD.
This study was a prospective follow-up after CHD risk assessment and intervention designed to determine whether middle-aged men identified as being at high risk of CHD in primary care, who participated in a randomized controlled trial of antithrombotic medication, reduced their risk factor profile in response to the health promotion given in all practices, whatever their treatment allocation. We studied 4316 men aged 45-69 years (who had not suffered a previous myocardial infarction or stroke) identified at screening in 81 general practices in the UK as being at high risk of coronary heart disease. The changes in the prevalence of smoking and in blood pressure, serum cholesterol level, body mass index and plasma fibrinogen level were recorded for a period of up to 2 years after entry into the trial. The use of standard health education materials and of more intensive individual interventions was substantial. There were regular opportunities through nurses and consultations with general practitioners for continuing advice about risk factors.
The prevalence of current smoking fell during the trial but it was still 37% at 2 years. There was a significant decrease in blood pressure due first to regression to the mean but then to the trial's treatment protocol and accommodation to measurement. There were small falls between screening and entry in body mass and levels of serum cholesterol and fibrinogen, again due largely to regression to the mean; subsequent changes in these characteristics were negligible.
Sustained and quite intensive health promotion activity had only a limited effect in men identified as being at high risk of CHD. In particular, there was little change in body mass or serum cholesterol. Although improved blood pressure control and a moderate reduction in the prevalence of smoking can be achieved, further research is needed to determine the most effective methods of risk factor reduction in order to realize the full potential of the 'high-risk' approach to the prevention of CHD.
在初级保健中,对冠心病(CHD)危险因素的识别与修正受到越来越多的关注。一种方法是将活动集中于那些冠心病高危人群。
本研究是一项冠心病风险评估与干预后的前瞻性随访,旨在确定在初级保健中被认定为冠心病高危的中年男性,无论其治疗分配如何,参与抗血栓药物随机对照试验后,是否会因所有医疗机构提供的健康促进措施而降低其危险因素水平。我们研究了在英国81家全科诊所筛查出的4316名年龄在45 - 69岁(既往未发生过心肌梗死或中风)的男性,他们被认定为冠心病高危人群。记录了进入试验后长达2年的吸烟率以及血压、血清胆固醇水平、体重指数和血浆纤维蛋白原水平的变化情况。标准健康教育材料和更强化的个体干预措施的使用很广泛。通过护士以及与全科医生的咨询,有定期机会获得关于危险因素的持续建议。
试验期间当前吸烟率有所下降,但2年后仍为37%。血压显著下降,首先是由于均值回归,但随后是由于试验的治疗方案以及对测量的适应性。在筛查与进入试验之间,体重、血清胆固醇和纤维蛋白原水平略有下降,同样主要是由于均值回归;这些特征随后的变化可忽略不计。
持续且相当强化的健康促进活动对被认定为冠心病高危的男性效果有限。特别是,体重或血清胆固醇几乎没有变化。尽管可以实现血压控制的改善以及吸烟率的适度降低,但仍需要进一步研究以确定降低危险因素的最有效方法,从而充分发挥“高危”预防冠心病方法的潜力。